Advertisement
Australia markets close in 44 minutes
  • ALL ORDS

    7,802.80
    -96.10 (-1.22%)
     
  • ASX 200

    7,552.10
    -90.00 (-1.18%)
     
  • AUD/USD

    0.6401
    -0.0025 (-0.38%)
     
  • OIL

    84.47
    +1.74 (+2.10%)
     
  • GOLD

    2,397.10
    -0.90 (-0.04%)
     
  • Bitcoin AUD

    97,052.87
    +643.10 (+0.67%)
     
  • CMC Crypto 200

    1,284.80
    +399.26 (+43.77%)
     
  • AUD/EUR

    0.6016
    -0.0015 (-0.24%)
     
  • AUD/NZD

    1.0880
    +0.0005 (+0.05%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,208.74
    -177.13 (-1.08%)
     
  • NIKKEI 225

    37,135.78
    -943.92 (-2.48%)
     

3 Blockbuster Drug Launches to Watch This Year

3 Blockbuster Drug Launches to Watch This Year

The coronavirus pandemic has impacted lots of industries but it didn't slow down the pace of new drug approvals. The FDA greenlighted 59 new drugs last year, and 2021 is shaping up to be a big year too. Read on to see why new drugs from GlaxoSmithKline (NYSE: GSK), Gilead Sciences (NASDAQ: GILD), and Eli Lilly (NYSE: LLY) made the list.